EP Patent

EP0303306B1 — Contraceptive implant

Assigned to Organon NV · Expires 1993-03-10 · 33y expired

What this patent protects

The invention relates to an implant of polymeric material which can release a contraceptive agent for a relatively long time when fitted subcutaneously or locally.

USPTO Abstract

The invention relates to an implant of polymeric material which can release a contraceptive agent for a relatively long time when fitted subcutaneously or locally.

Drugs covered by this patent

Nexplanon (ETONOGESTREL)

Patent Metadata

Patent number: EP0303306B1
Jurisdiction: EP
Classification: —
Expires: 1993-03-10
Drug substance claim: No
Drug product claim: No
Assignee: Organon NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.